Cafepharma Today

June 9 2025 - Merck claims study success with PCSK9 cholesterol pill
Merck claims study success with PCSK9 cholesterol pill
FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer
Drug imports plummeted in April despite tariff threat
Sanofi starts shipping RSV drug early as rival nears market
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

PropThink: Previewing Gilead's 'Quad' Ahead of FDA Decision
Yahoo/Reuters
Friday, August 24, 2012 - 10:59am
tags:
FDA, Quad, HIV, Gilead
Bristol to take $1.8 billion charge on hepatitis C drug failure
Reuters
Friday, August 24, 2012 - 10:33am
tags:
Bristol-Myers Squibb, hepatitis C, BMS-986094
Analysts: Roche's armed antibody will help drive breast cancer drug sales
Fierce Biotech
Thursday, August 23, 2012 - 10:24am
tags:
Roche, breast cancer, T-DM1
Will 'gamifying' drug R&D win more than Facebook fans for Boehringer?
Fierce Pharma
Thursday, August 23, 2012 - 10:22am
tags:
social media, Facebook, Boehringer Ingelheim, R&D
Pfizer, Mylan unveil generic tie-up in Japan
Yahoo/AFP
Thursday, August 23, 2012 - 10:14am
tags:
Pfizer, Japan, Mylan, generics
Spectrum Still Won't Answer Relevant Questions About Fusilev Discounts
TheStreet.com
Thursday, August 23, 2012 - 10:11am
tags:
Spectrum Pharmaceuticals, Fusilev
India's pharma reps strike over corruption perceptions
Pharmalot
Thursday, August 23, 2012 - 10:10am
tags:
strike, India, drug reps
Gilead Sciences Will Continue To Grow
Seeking Alpha
Thursday, August 23, 2012 - 10:04am
tags:
Gilead
GlaxoSmithKline, J&J to start rheumatoid arthritis drug trial
Reuters
Thursday, August 23, 2012 - 10:02am
tags:
GSK, JNJ, rheumatoid arthritis, sirukumab
Sanofi Launches Sklice in the US
Yahoo/Zacks
Thursday, August 23, 2012 - 10:00am
tags:
Sanofi, Sklice, head lice, lice
Should Arena Hold Off On New Marketing And Supply Agreements?
Seeking Alpha
Thursday, August 23, 2012 - 9:59am
tags:
Belviq, Arena Pharmaceuticals, Eisai
XOMA Receives Orphan Drug Designation From U.S. Food & Drug Administration for Gevokizumab
Yahoo
Thursday, August 23, 2012 - 9:58am
tags:
Xoma, FDA, orphan drugs, gevokizumab, uveitis
How Do Oncologists Sort Through All the New Anticancer Drugs?
Forbes
Thursday, August 23, 2012 - 9:56am
tags:
oncologists, cancer, physicians
Novel Lipid Management Therapies In High-Risk Patients - A Paradigm Shift
Seeking Alpha
Thursday, August 23, 2012 - 9:55am
tags:
Aegerion, Isis Pharmaceuticals, LDL cholesterol, lomitapide, mipomersen
3 Reasons to Sell: VIVUS
Motley Fool
Thursday, August 23, 2012 - 9:54am
tags:
Vivus, patents, Qsymia
Pfizer's Latest Drug Could Result In Significant Growth If Approved
Seeking Alpha
Thursday, August 23, 2012 - 9:53am
tags:
Pfizer, Abbott Laboratories, tofacitinib, rheumatoid arthritis
Merck Gives InSite A Gift; What Does It Mean?
Seeking Alpha
Thursday, August 23, 2012 - 9:52am
tags:
Merck, InSite Vision
Pfizer Asks End To Fen-Phen Suits Linked To Lung Ailment
Bloomberg
Thursday, August 23, 2012 - 9:42am
tags:
Pfizer, Fen-Phen, Wyeth, primary pulmonary hypertension, PPH
Latest Drug Sales Data: Loss of Patent Protection Has Significant Effect, According to Drugs.com
Pharma Live
Wednesday, August 22, 2012 - 11:54am
tags:
drug sales, patents, generics
Big BioPharma Stock Buybacks: Are There Better Alternatives?
Forbes
Wednesday, August 22, 2012 - 11:44am
tags:
stock buybacks

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.